SCHEMBL27660907

SCHEMBL27660907

CCOP(=O)(OCC)c1cccc(F)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPSR1 Q6W5P4 2/20 0.47
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
MMP9 P14780 2/20 0.44
MMP1 P03956 1/20 0.44
MMP3 P08254 1/20 0.44
ADAM17 P78536 1/20 0.44
ADAM9 Q13443 1/20 0.44
ALDH1A1 P00352 1/20 0.43
CA12 O43570 2/20 0.42
CA1 P00915 2/20 0.42
CA2 P00918 2/20 0.42
CA9 Q16790 2/20 0.42
ACHE P22303 2/20 0.41
CCNT1 O60563 1/20 0.39
CDK9 P50750 1/20 0.39
KDM4E B2RXH2 1/20 0.39
CA4 P22748 1/20 0.39
CA5A P35218 1/20 0.39
CA7 P43166 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL778099 0.86 MEN1 (0.44) NPSR1MEN1KMT2AMMP9MMP1
SCHEMBL4148573 0.81 POLB (0.39) NPSR1MEN1KMT2AALDH1A1CA12
SCHEMBL15871416 0.80 NPSR1 (0.48) NPSR1MEN1KMT2ACA12CA1
SCHEMBL12230075 0.79 ACHE (0.40) MEN1KMT2AALDH1A1CA12CA2
SCHEMBL12229697 0.79 NPSR1 (0.45) NPSR1MEN1KMT2AALDH1A1CA12
SCHEMBL4411677 0.79 NPSR1 (0.47) NPSR1MEN1KMT2ACA12CA1
SCHEMBL13636979 0.79 NPSR1 (0.47) NPSR1MEN1KMT2AALDH1A1CA12
SCHEMBL2034316 0.79 NPSR1 (0.47) NPSR1MEN1KMT2ACA12CA1
SCHEMBL2364152 0.79 MEN1 (0.54) NPSR1MEN1KMT2AALDH1A1CA12
SCHEMBL12229683 0.79 POLB (0.53) NPSR1MEN1KMT2AALDH1A1CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1989141-B Bicyclic heterocycles as HIV integrase inhibitors BRISTOL MYERS SQUIBB CO 2010-06-16 CN disclosed
CN-1989141-A Bicyclic heterocycles as HIV integrase inhibitors BRISTOL MYERS SQUIBB CO (US) 2007-06-27 CN disclosed